English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background:  The analysis of the gene copy number alterations in tumor samples are increasingly used for diagnostic and prognostic purposes in patients with GC. However, these procedures are not always applicable due to their invasive nature. In this study, we have analyzed the copy number alterations of five genes ( HER2 ,  MDM2 ,  c-MYC ,  c-MET , and  TP53 ) with a fixed relevance for GC in the CTC of GC patients, and, accordingly, as a potential approach, evaluated their usage to complete primary tumor biopsy.Methods:  We analyzed the status of the copy number alterations of the selected genes in CTC and matched biopsy tissues from 37 GC patients using FISH.Results:    HER2  amplification was observed in 2 (5.41%) samples.  HER2  gene status in CTC showed a strong agreement with its status in 36 out of 37 patients’ matched tissue samples (correlation: 97.29%; Kappa: 0.65;  p  < 0.001).  MDM2  amplification was found only in 1 (2.70%) sample; however, the amplification of this gene was not detectable in the CTC isolated from this patient.  c-MYC  amplification was observed in 3 (8.11%) samples, and the status of its amplification in the CTC indicated a complete agreement with its status in the matched tissue samples (correlation: 100%; Kappa: 1.0).Conclusion:  Our work suggests that the amplification of  HER2  and  c-MYC  is in concordance with the CTC and achieved biopsies, and, consequently, CTC may act as a non-invasive alternative for recording the amplification of these genes among GC patients.

iranian biomedical journal.

Correlation of HER2, MDM2, c-MYC, c-MET, and TP53 Copy Number Alterations in Circulating Tumor Cells with Tissue in Gastric Cancer Patients: A Pilot Study